The effects of supplemented diets with a phytopharmaceutical preparation from herbal and macroalgal origin on disease resistance in rainbow trout against Piscirickettsia salmonis

datacite.alternateIdentifier.citationAquaculture, 454, 117-109, 2016
datacite.alternateIdentifier.doi10.1016/j.aquaculture.2015.12.016
datacite.alternateIdentifier.issn0044-8486
datacite.creatorHernandez, Adrian J.
datacite.creatorRomero, Alex
datacite.creatorGonzalez-Stegmaier, Roxana
datacite.creatorDantagnan, Patricio
datacite.date2016
datacite.rightsRegistro bibliográfico
datacite.subjectPhytopharmaceuticals
datacite.subjectLabdane diterpenes
datacite.subjectFucoidans
datacite.subjectImmunostimulants
datacite.subjectOncorhynchus mykiss
datacite.subjectPiscirickettsia salmonis
datacite.titleThe effects of supplemented diets with a phytopharmaceutical preparation from herbal and macroalgal origin on disease resistance in rainbow trout against Piscirickettsia salmonis
dc.contributor.authorDANTAGNAN DANTAGNAN, HERMAN PATRICIO
dc.contributor.authorHERNANDEZ ARIAS, ADRIAN JESUS
dc.date.accessioned2025-10-06T14:21:42Z
dc.date.available2025-10-06T14:21:42Z
dc.description.abstractThe present study aimed to evaluate the effects of a commercial phytopharmaceutical preparation from herbal and macroalgal origin on the growth and immune response of rainbow trout adapted to seawater and its susceptibility to Piscirickettsia salmonis infection. Preliminary in vitro trials, evaluated the effects of the commercial product Futerpenol (R) on the expression levels of selected immune-regulatory genes and its protective effect in a challenge against Piscirickettsia salmonis (LF89). Subsequent in vivo feeding trials were conducted to corroborate fish protection against Piscirickettsia salmonis. Control and treatment diets (with or without the commercial product Futerpenol (R) at a concentration of 1 kg/ton) were fed to triplicate groups of 50 fish (average weight: 100.1 +/- 11.1 g) during 30 days. Fish from all dietary groups were equally redistributed in three tanks and challenged by cohabitation with fish infected with P. salmonis (shedders) at the end of the feeding treatment, and mortalities were recorded over 80 days post-infection. A cumulative mortality of 35.0 +/- 4.3 and 15.0 +/- 6.0% was registered when challenged fish were previously fed during 30 days with the control and treatment diets respectively. Futerpenol (R) dietary administration preceding the cohabitation challenge gave significant protection from P. salmonis as suggested by the Relative Percent Survival (RPS) values of 62.3 and 57.1% after 60 and 80 days post-infection, respectively. These results suggest that dietary supplementation with Futerpenol (R) at 1 kg/ton do not affect growth performance and strengthen immunity of Oncorhynchus mykiss against P. salmonis under the experimental conditions applied during this study. Statement of relevance: This study demonstrates that dietary supplementation with a phytopharmaceutical preparation, rich in fucoidans and labdane diterpenes strengthen immunity of O. mykiss against P. salmonis. The use of feed supplemented with this kind of phytopharmaceutical preparations in anticipation to potential infections or vulnerable stages of the production could be useful as an alternative method to prevent and limit the outbreak of salmonid rickettsial septicaemia (SRS) which constitutes one of the main infectious diseases causing production problems and substantial loss in salmonids and marine fish aquaculture worldwide. (C) 2015 Elsevier B.V. All rights reserved.
dc.description.ia_keywordsalmonis, fish, against, were, phytopharmaceutical, piscirickettsia, futerpenol
dc.identifier.issn1873-5622
dc.identifier.urihttps://repositoriodigital.uct.cl/handle/10925/6751
dc.language.isoen
dc.publisherElsevier BV
dc.relationinstname: ANID
dc.relationreponame: Repositorio Digital RI2.0
dc.rights.driverinfo:eu-repo/semantics/openAccess
dc.sourceAquaculture
dc.subject.ia_odsODS 3: Salud y bienestar
dc.subject.ia_oecd1nCiencias Médicas y de la Salud
dc.subject.ia_oecd2nMedicina Clínica
dc.subject.ia_oecd3nMedicina Clínica
dc.type.driverinfo:eu-repo/semantics/article
dc.type.driverhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.type.openaireinfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication
oaire.citationEdition2016
oaire.citationEndPage117
oaire.citationStartPage109
oaire.citationTitleAquaculture
oaire.citationVolume454
oaire.fundingReferenceANID FONDECYT 1141006 (Regular)
oaire.fundingReferenceANID FONDAP 15110027
oaire.fundingReferenceCORFO 12ETN18828
oaire.licenseConditionCopyright © Elsevier Inc, 2015
oaire.resourceTypeArtículo
oaire.resourceType.enArticle
relation.isAuthorOfPublication9ed02e88-c517-44ff-b002-91dfa5b40b99
relation.isAuthorOfPublicationd6879a45-cf2a-418d-8f5e-0773cf35f4dd
relation.isAuthorOfPublication.latestForDiscovery9ed02e88-c517-44ff-b002-91dfa5b40b99
uct.catalogadorjvu
uct.comunidadRecursos Naturalesen_US
uct.departamentoDepartamento de Ciencias Agropecuarias y Acuícolas
uct.facultadFacultad de Recursos Naturales
uct.indizacionScience Citation Index Expanded - SCIE
uct.indizacionSCOPUS
uct.indizacionWOS
uct.indizacionDOAJ
Files